Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands

Abstract Little is known about the key molecules that regulate cell division during organogenesis. Here we determine the role of the cell cycle promoter aurora kinase B (AURKB) during development, using embryonic salivary glands (E-SGs) as a model. AURKB is a serine/threonine kinase that regulates k...

Full description

Bibliographic Details
Main Authors: Abeer K. Shaalan, Tathyane H. N. Teshima, Abigail S. Tucker, Gordon B. Proctor
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-020-00393-w
id doaj-86853b363a494d7bac37b6b990c63f0a
record_format Article
spelling doaj-86853b363a494d7bac37b6b990c63f0a2021-01-24T12:43:53ZengNature Publishing GroupCell Death Discovery2058-77162021-01-017111210.1038/s41420-020-00393-wInhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glandsAbeer K. Shaalan0Tathyane H. N. Teshima1Abigail S. Tucker2Gordon B. Proctor3Centre for Host-Microbiome Interactions, Guy’s Hospital, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College LondonCentre for Craniofacial and Regenerative Biology, Guy’s Hospital, Faculty of Dentistry, Oral and Craniofacial Sciences, King’s College LondonCentre for Craniofacial and Regenerative Biology, Guy’s Hospital, Faculty of Dentistry, Oral and Craniofacial Sciences, King’s College LondonCentre for Host-Microbiome Interactions, Guy’s Hospital, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College LondonAbstract Little is known about the key molecules that regulate cell division during organogenesis. Here we determine the role of the cell cycle promoter aurora kinase B (AURKB) during development, using embryonic salivary glands (E-SGs) as a model. AURKB is a serine/threonine kinase that regulates key events in mitosis, which makes it an attractive target for tailored anticancer therapy. Many reports have elaborated on the role of AURKB in neoplasia and cancer; however, no previous study has shown its role during organ development. Our previous experiments have highlighted the essential requirement for AURKB during adult exocrine regeneration. To investigate if AURKB is similarly required for progression during embryonic development, we pharmacologically inhibited AURKB in developing submandibular glands (SMGs) at embryonic day (E)13.5 and E16.5, using the highly potent and selective drug Barasertib. Inhibition of AURKB interfered with the expansion of the embryonic buds. Interestingly, this effect on SMG development was also seen when the mature explants (E16.5) were incubated for 24 h with another cell cycle inhibitor Aphidicolin. Barasertib prompted apoptosis, DNA damage and senescence, the markers of which (cleaved caspase 3, γH2AX, SA-βgal and p21, respectively), were predominantly seen in the developing buds. In addition to a reduction in cell cycling and proliferation of the epithelial cells in response to AURKB inhibition, Barasertib treatment led to an excessive generation of reactive oxygen species (ROS) that resulted in downregulation of the acinar differentiation marker Mist1. Importantly, inhibition of ROS was able to rescue this loss of identity, with Mist1 expression maintained despite loss of AURKB. Together, these data identify AURKB as a key molecule in supporting embryonic development and differentiation, while inhibiting senescence-inducing signals during organogenesis.https://doi.org/10.1038/s41420-020-00393-w
collection DOAJ
language English
format Article
sources DOAJ
author Abeer K. Shaalan
Tathyane H. N. Teshima
Abigail S. Tucker
Gordon B. Proctor
spellingShingle Abeer K. Shaalan
Tathyane H. N. Teshima
Abigail S. Tucker
Gordon B. Proctor
Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands
Cell Death Discovery
author_facet Abeer K. Shaalan
Tathyane H. N. Teshima
Abigail S. Tucker
Gordon B. Proctor
author_sort Abeer K. Shaalan
title Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands
title_short Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands
title_full Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands
title_fullStr Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands
title_full_unstemmed Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands
title_sort inhibition of aurora kinase b activity disrupts development and differentiation of salivary glands
publisher Nature Publishing Group
series Cell Death Discovery
issn 2058-7716
publishDate 2021-01-01
description Abstract Little is known about the key molecules that regulate cell division during organogenesis. Here we determine the role of the cell cycle promoter aurora kinase B (AURKB) during development, using embryonic salivary glands (E-SGs) as a model. AURKB is a serine/threonine kinase that regulates key events in mitosis, which makes it an attractive target for tailored anticancer therapy. Many reports have elaborated on the role of AURKB in neoplasia and cancer; however, no previous study has shown its role during organ development. Our previous experiments have highlighted the essential requirement for AURKB during adult exocrine regeneration. To investigate if AURKB is similarly required for progression during embryonic development, we pharmacologically inhibited AURKB in developing submandibular glands (SMGs) at embryonic day (E)13.5 and E16.5, using the highly potent and selective drug Barasertib. Inhibition of AURKB interfered with the expansion of the embryonic buds. Interestingly, this effect on SMG development was also seen when the mature explants (E16.5) were incubated for 24 h with another cell cycle inhibitor Aphidicolin. Barasertib prompted apoptosis, DNA damage and senescence, the markers of which (cleaved caspase 3, γH2AX, SA-βgal and p21, respectively), were predominantly seen in the developing buds. In addition to a reduction in cell cycling and proliferation of the epithelial cells in response to AURKB inhibition, Barasertib treatment led to an excessive generation of reactive oxygen species (ROS) that resulted in downregulation of the acinar differentiation marker Mist1. Importantly, inhibition of ROS was able to rescue this loss of identity, with Mist1 expression maintained despite loss of AURKB. Together, these data identify AURKB as a key molecule in supporting embryonic development and differentiation, while inhibiting senescence-inducing signals during organogenesis.
url https://doi.org/10.1038/s41420-020-00393-w
work_keys_str_mv AT abeerkshaalan inhibitionofaurorakinasebactivitydisruptsdevelopmentanddifferentiationofsalivaryglands
AT tathyanehnteshima inhibitionofaurorakinasebactivitydisruptsdevelopmentanddifferentiationofsalivaryglands
AT abigailstucker inhibitionofaurorakinasebactivitydisruptsdevelopmentanddifferentiationofsalivaryglands
AT gordonbproctor inhibitionofaurorakinasebactivitydisruptsdevelopmentanddifferentiationofsalivaryglands
_version_ 1724325471615713280